These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25446139)

  • 1. Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in Europe.
    Ram-Liebig G; Bednarz J; Stuerzebecher B; Fahlenkamp D; Barbagli G; Romano G; Balsmeyer U; Spiegeler ME; Liebig S; Knispel H
    Adv Drug Deliv Rev; 2015 Mar; 82-83():181-91. PubMed ID: 25446139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [European Marketing Authorisation: a long process. Experiences of small biotech companies with the ATMP regulation].
    Buljovčić Z
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):831-8. PubMed ID: 21698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulatory framework of innovative therapies : From bench to bedside].
    Walter C; Rohde B; Wicke DC; Pohler C; Lührmann A; von der Leyen H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):803-10. PubMed ID: 21698532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory barriers to tissue-engineered products.
    Schutte E
    Med Device Technol; 2002 Mar; 13(2):27-9. PubMed ID: 11984990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues with Tissues: Trends in Tissue-Engineered Products in Clinical Trials in the European Union.
    Joyce K; Buljovcic Z; Rosic G; Kaszkin-Bettag M; Pandit A
    Tissue Eng Part B Rev; 2023 Feb; 29(1):78-88. PubMed ID: 36062927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EU.
    Brévignon-Dodin L
    Biomed Mater Eng; 2010; 20(3):121-6. PubMed ID: 20930319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical considerations in tissue engineering research: Case studies in translation.
    Baker HB; McQuilling JP; King NM
    Methods; 2016 Apr; 99():135-44. PubMed ID: 26282436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Legal regulation in the field of tissue engineering].
    Farkas B; Bárdos T; Bellyei A; Illés T
    Orv Hetil; 2008 Jun; 149(22):1023-8. PubMed ID: 18508736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States.
    Lee MH; Arcidiacono JA; Bilek AM; Wille JJ; Hamill CA; Wonnacott KM; Wells MA; Oh SS
    Tissue Eng Part B Rev; 2010 Feb; 16(1):41-54. PubMed ID: 19728784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical assessment of the directive on tissue engineering of the European union.
    Trommelmans L; Selling J; Dierickx K
    Tissue Eng; 2007 Apr; 13(4):667-72. PubMed ID: 17253926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational research on advanced therapies.
    Belardelli F; Rizza P; Moretti F; Carella C; Galli MC; Migliaccio G
    Ann Ist Super Sanita; 2011; 47(1):72-8. PubMed ID: 21430343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What can be learnt from the Japanese regulatory approach to tissue engineered products?
    Brévignon-Dodin L; Livesey F
    Regen Med; 2007 Nov; 2(6):967-71. PubMed ID: 18034634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating autologous heart valve tissue engineering from bench to bed.
    Hjortnaes J; Bouten CV; Van Herwerden LA; Gründeman PF; Kluin J
    Tissue Eng Part B Rev; 2009 Sep; 15(3):307-17. PubMed ID: 19450137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tissue-engineered products in the European Union: where are we heading?
    Brévignon-Dodin L; Livesey F
    Regen Med; 2006 Sep; 1(5):709-14. PubMed ID: 17465739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A European regulatory pathway for tissue engineering--at last.
    Williams D
    Med Device Technol; 2007 Sep; 18(5):8, 10-1. PubMed ID: 17939364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation.
    de Wilde S; Veltrop-Duits L; Hoozemans-Strik M; Ras T; Blom-Veenman J; Guchelaar HJ; Zandvliet M; Meij P
    Cytotherapy; 2016 Jun; 18(6):797-805. PubMed ID: 27068764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The translation of product concept to bone products: a partnership of therapeutic effectiveness and commercialization.
    Ratcliffe A
    Tissue Eng Part B Rev; 2011 Dec; 17(6):443-7. PubMed ID: 21790510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-engineered buccal mucosa urethroplasty-clinical outcomes.
    Bhargava S; Patterson JM; Inman RD; MacNeil S; Chapple CR
    Eur Urol; 2008 Jun; 53(6):1263-9. PubMed ID: 18262717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How smart do biomaterials need to be? A translational science and clinical point of view.
    Holzapfel BM; Reichert JC; Schantz JT; Gbureck U; Rackwitz L; Nöth U; Jakob F; Rudert M; Groll J; Hutmacher DW
    Adv Drug Deliv Rev; 2013 Apr; 65(4):581-603. PubMed ID: 22820527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.